Skip to content

Minimum inhibitory concentrations of standard and novel drugs for bacterial keratitis

New research from the Department of Ophthalmology and Medical Microbiology at Royal Liverpool University Hospital has reported on the susceptibility of 722 bacterial isolates from patients who presented with suppurative keratitis. The data revealed that Meropenem, a newer anti-microbial potentially suitable for ophthalmic use, may represent the best choice for empiric monotherapy in bacterial keratitis.